Tag: ex vivo hematopoietic stem cell
CSL Behring buys US biotech company Calimmune
CSL Behring, the major operating arm of the CSL Group, has agreed to acquire US Biotechnology company Calimmune, Inc. for an upfront payment of...
Featured Article
From cost exposure to cost control: Using energy flexibility to protect margins
Electricity price volatility is reshaping the cost base of Australian manufacturing, challenging long-held assumptions that energy can be treated as a stable operational input.
